REG - IQE PLC - IQE plc: Total Voting Rights and Block Admission

IqeAnnouncement

09/01/2023 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230109:nRSI0866Ma&default-theme=true

RNS Number : 0866M  IQE PLC  09 January 2023

IQE plc

 

 

Total Voting Rights and Block Admission Return

 

 

Cardiff, UK

9 January 2023

 

 

("IQE" or the "Company")

 

Total Voting Rights

As at 31 December 2022, the Company's issued share capital consisted of
804,846,080 ordinary shares of 1 pence each ("Ordinary Shares"). The Company
holds 4,115 Ordinary Shares in treasury. Therefore the total number Ordinary
Shares with voting rights in the Company is 804,841,965.

 

Shareholders may use this figure (804,841,965) as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the Financial
Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Block Admission Return

The Company hereby provides an update to its block admission filed on 1 July
2022.

 

 Name of company:                                                              IQE plc

 Name of scheme:                                                               All employee share option plan

 Period of return:                                                             1 July 2022 to 31 December 2022

 Number of Ordinary Shares not issued under scheme at the end of the last      6,985,949
 period:

 Number of Ordinary Shares issued under scheme during period:                  283,248

 Number of Ordinary Shares cancelled under the scheme during period:           Nil

 Number of Ordinary Shares added to the scheme during period:                  0

 Balance of Ordinary Shares under scheme not yet issued at end of period:      6,702,701

 Number and class of Ordinary Shares originally admitted under scheme and the  1,000,000 Ordinary Shares (4 Dec 2009)
 date of admission:

                                                                               2,000,000 Ordinary Shares (11 Oct 2010)

                                                                               5,000,000 Ordinary Shares (8 Nov 2010)

                                                                               8,000,000 Ordinary Shares (5 Apr 2011)

                                                                               6,000,000 Ordinary Shares (16 May 2012)

                                                                               16,000,000 Ordinary shares (19 Jun 2012)

                                                                               8,000,000 Ordinary shares (12 Aug 2014)

                                                                               8,000,000 Ordinary shares (3 Dec 2015)

                                                                               12,000,000 Ordinary shares (20 April 2017)

                                                                               14,000,000 Ordinary shares (12 June 2018)

                                                                               12,000,000 Ordinary shares (25 January 2019)

                                                                               3,000,000 Ordinary shares (25 January 2020)

                                                                               8,000,000 Ordinary shares (4 May 2021)

 

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Amy Barlow

 

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

James Smith

 

Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

 

ABOUT IQE

http://iqep.com
(https://www.globenewswire.com/Tracker?data=yZf7NKp1JKLALUCxlBuC8wkLnLAqoe5-kjjIlkMIDci9q9W0x_02bwZV-eorSbpLXZxy4zi3xHh-O4FM8nWjeg==)

 

IQE is the leading global supplier of advanced compound semiconductor wafers
and materials solutions that enable a diverse range of applications across:

 

·    handset devices

·    global telecoms infrastructure

·    connected devices

·    3D Sensing

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in
this market which has high barriers to entry. IQE supplies the whole market
and is agnostic to the winners and losers at chip and OEM level. By leveraging
the Group's intellectual property portfolio including know-how and patents, it
produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 685 employees across nine
manufacturing locations in the UK, US and Taiwan, and is listed on the AIM
Stock Exchange in London.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRKKLBBXFLFBBQ